Intangible Assets - Additional Information (Details) (USD $)
In Thousands, unless otherwise specified |
12 Months Ended | |||||
---|---|---|---|---|---|---|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Dec. 31, 2011
|
Dec. 31, 2008
|
Dec. 31, 2009
Patents
|
|
Finite Lived Intangible Assets [Line Items] | ||||||
Estimated useful life of intangible asset | 2 years | |||||
Purchased additional patents | $ 205us-gaap_PaymentsToAcquireIntangibleAssets | $ 37us-gaap_PaymentsToAcquireIntangibleAssets | $ 63us-gaap_PaymentsToAcquireIntangibleAssets | |||
Amortization of intangible assets | 150us-gaap_AmortizationOfIntangibleAssets | 203us-gaap_AmortizationOfIntangibleAssets | 298us-gaap_AmortizationOfIntangibleAssets | |||
Patient setup video, Website development, redesign and commercials | ||||||
Finite Lived Intangible Assets [Line Items] | ||||||
Cost incurred for advertising |
63us-gaap_AdvertisingRevenueCost / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = ingn_PatientSetupVideoWebsiteDevelopmentRedesignAndCommercialsMember |
95us-gaap_AdvertisingRevenueCost / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = ingn_PatientSetupVideoWebsiteDevelopmentRedesignAndCommercialsMember |
||||
Comfort Life Medical, LLC | ||||||
Finite Lived Intangible Assets [Line Items] | ||||||
Acquisition of intangible asset |
92us-gaap_FinitelivedIntangibleAssetsAcquired1 / dei_LegalEntityAxis = ingn_ComfortLifeMedicalLLCMember |
|||||
Estimated useful life of intangible asset | 10 years | |||||
Impairments |
0us-gaap_AssetImpairmentCharges / dei_LegalEntityAxis = ingn_ComfortLifeMedicalLLCMember |
0us-gaap_AssetImpairmentCharges / dei_LegalEntityAxis = ingn_ComfortLifeMedicalLLCMember |
||||
Air Products & Chemicals | ||||||
Finite Lived Intangible Assets [Line Items] | ||||||
Acquisition of intangible asset |
250us-gaap_FinitelivedIntangibleAssetsAcquired1 / dei_LegalEntityAxis = ingn_AirProductsChemicalsMember |
|||||
Estimated useful life of intangible asset | 5 years | |||||
Impairments |
0us-gaap_AssetImpairmentCharges / dei_LegalEntityAxis = ingn_AirProductsChemicalsMember |
0us-gaap_AssetImpairmentCharges / dei_LegalEntityAxis = ingn_AirProductsChemicalsMember |
||||
Number of patents |
4us-gaap_GainContingencyPatentsFoundInfringedUponNumber / dei_LegalEntityAxis = ingn_AirProductsChemicalsMember |
|||||
Increase in long term liability |
250us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt / dei_LegalEntityAxis = ingn_AirProductsChemicalsMember |
|||||
Purchased additional patents |
650us-gaap_PaymentsToAcquireIntangibleAssets / dei_LegalEntityAxis = ingn_AirProductsChemicalsMember |
|||||
Reduced underlying asset and debt |
177us-gaap_AmountOfImpairmentToCarryingAmountOfRegulatoryAssets / dei_LegalEntityAxis = ingn_AirProductsChemicalsMember |
|||||
Breathe Oxygen Services, LLC | ||||||
Finite Lived Intangible Assets [Line Items] | ||||||
Acquisition of intangible asset |
66us-gaap_FinitelivedIntangibleAssetsAcquired1 / dei_LegalEntityAxis = ingn_BreatheOxygenServicesLLCMember |
|||||
Estimated useful life of intangible asset | 10 years | |||||
Impairments |
$ 0us-gaap_AssetImpairmentCharges / dei_LegalEntityAxis = ingn_BreatheOxygenServicesLLCMember |
$ 0us-gaap_AssetImpairmentCharges / dei_LegalEntityAxis = ingn_BreatheOxygenServicesLLCMember |
X | ||||||||||
- Definition
Costs incurred and are directly related to generating advertising revenues. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Discloses the amount of any reduction to the carrying amounts of regulated assets that result from impairment (for example, rate actions of a regulator). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of long-term debt due within one year or within the normal operating cycle, if longer, assumed at the acquisition date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, resulting from a business combination. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
X | ||||||||||
- Definition
Number of entity's patents that another entity was found to have infringed. No definition available.
|
X | ||||||||||
- Definition
The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|